fda approved semaglutide Novo Nordisk's weight-loss pill wins approval Novo Nordisk's Ozempic® pill, the

Clinical and Real-World Evidence of GLP-1s on Cravings Studies show reduced hunger and calorie intake, but craving-related effects are based on early research and patient reports rather than confirmed clinical trials

If a consumer is eating less, the eating experience needs to be worth it. A reduced appetite may make it challenging to maintain adequate nutrient intake while taking GLP-1 medication, so food formulators have an opportunity to close the gap

A significant number of metabolic enzymes require Copper to function properly

Gastric emptying is particularly problematic during endoscopy because it increases the risk of aspiration by producing retained gastric contents, which interfere with visualization during esophagogastroduodenoscopy (EGD)

The impact of GLP-1 drugs on bariatric surgery (weight loss surgery) is an example of the latter - competition that snuck up quietly but then manifested severely and rapidly